| 영문 | receptor | 한글 | 수용체 |
|---|---|---|---|
| 설명 | 세포질내 또는 세포표면에 존재하는 분자구조로서 특이물질과 선택적으로 결합하며 결합에 의해 특이한 생리적 작용을 나타낸다. 펩티드호르몬, 신경전달물질, 항원, 보체, 면역글로불린에 대한 세포표면 수용체와 스테로이드에 대한 세포질내 수용체가 있다. |
||
| 영문 | basal layer of skin | 한글 | 기저층 |
|---|---|---|---|
| 설명 | 표피의 가장 아래 부분이며 세포의 모양이 비교적 직사각형에 가깝고 일정한 배열을 한다. |
||
| 영문 | skin tag | 한글 | 쥐젖, 피부연성섬유종 |
|---|---|---|---|
| 설명 | 주로 목, 겨드랑이, 다리에 생기는 살색 또는 과색소 침착성의 작은 목을 가진 섬유성 돌출물로 대개 무증상이다. |
||
| 영문 | skin | 한글 | 피부 |
|---|---|---|---|
| 설명 | 신체를 싸고 있는 바깥층으로서 표피, 진피, 피하조직으로 구성되며, 외부 환경으로부터 신체를 보호하고 체온을 조절하는 기능을 가짐. 1.표피: 피부의 가장 바깥층으로서 외배엽에서 기원하며 각질이라는 구조 단백질을 생산하는 기능을 가짐. 4가지의 세포가 있는데, 각질세포, 멜라닌세포, Langerhans 세포, 부정형 세포, Merkel세포가 있다. 표피에는 이 4가지 세포외에 다음과 같은 표피 부속기가 있다. 에크린 땀샘(eccrine sweat gland): 점막 피부 경계 부위 등 특수한 부위를 제외한 모든 피부에서 발견되며 땀을 분비하는 샘으로서 신체 열 조절 체계의 중요한 요소. 아포크린샘(apocrine gland): 겨드랑이, 젖꽃판, 항문 생식기 부위, 외이도, 눈꺼풀 등에서만 발견되며 분비물의 기능은 잘 알려져 있지 않으나 동물에서는 방어 및 성적 기능이 있음. 털주머니(hair follicle): 손바닥, 발바닥 등 특수 부위를 제외한 신체 전 부위에 분포하며 인간에서 중요한 생리적 기능은 없으나 성적 매력을 지니는 신체 장식의 기능을 가짐. 기름샘(sebaceous gland): 손바닥과 발바닥을 제외한 전 피부에 분포하며 분비물을 기름(sebum)라 부름. 남성 호르몬의 자극에 의해 성장하며 생리적 기능은 잘 알려져 있지 않음. 손발톱(nail) 2. 진피: 표피 아래에 존재하는 중배엽 기원의 조직으로서 혈관, 림프관, 신경, 근육, 표피 부속기 등을 포함하고 있음. 표피 바로 밑의 부위를 유두 진피라 하고 아래층을 망상 진피라 한다. 조직 섬유에는 아교질 섬유, 그물 섬유, 탄력 섬유의 세 종류가 있다. 3. 피하 조직: 진피 아래에 존재하며 중배엽 기원으로서 보온 작용, 충격 흡수 작용, 영양 저장 작용의 기능이 있다. |
||
| 영문 | skin dose | 한글 | 피부선량 |
|---|---|---|---|
| 설명 | 1. 피부표면에서의 방사선의 공중선량으로 여기에는 1차방사선과 후방산란이 포함된다. 2. 피부에 흡수되는 선량. |
||
| GPHN | giant pigmented hairy nevus |
|---|---|
| HC | hair cell; hairy cell; handicapped; head circumference; head compression; health care; healthy contr... |
| HCL | hairy-cell leukemia; human cultured lymphoblasts |
| HL | hairline; hairy leukoplakia; half life; hearing level; hearing loss; heparin lock; histiocytic lymph... |
| OHL | oral hairy leukoplakia |
| HCL | Hairy Cell Leukaemia |
|---|---|
| HC | Hairy Cells |
| HL | Hairy leucoplakia |
| OHL | Oral "hairy" leukoplakia |
| Su(Hw) | Suppressor of Hairy wing |
Nd:YAG
| giant hairy nevus | <dermatology> These large pigmented (often hairy) congenital nevi are important because of their increased risk (10 to 15%) of conversion into malignant melanoma. A biopsy can confirm if cells have turned malignant. Any change in a pre-existing nevus should prompt a physician evaluation. (17 Dec 1997) |
|---|---|
| hairy | A pair rule gene of Drosophila. (18 Nov 1997) |
| hairy cell leukaemia | <haematology, oncology> A rare chronic disorder characterised by proliferation of hairy cells in reticuloendothelial organs and blood. Origin: Gr. Haima = blood (13 Nov 1997) |
| hairy cells | Medium sized leukocytes that have features of reticuloendothelial cell's and multiple cytoplasmic projections (hairs) on the cell surface, but which may be a variety of B lymphocyte; they are found in hairy cell leukaemia. (05 Mar 2000) |
| hairy heart | Acute pericarditis with fibrinous exudate. See: bread-and-butter pericardium. Synonym: hairy heart, pericarditis villosa, shaggy pericardium. (05 Mar 2000) |
| hairy leukoplakia | <dermatology, gastroenterology> A white lesion appearing on the tongue, occasionally on the buccal mucosa, of patients with AIDS, the lesion appears raised, with a corrugated or hairy surface due to keratin projections. (13 Nov 1997) |
| hairy mole | A mole covered with an abundant growth of hair. Synonym: hairy mole. (05 Mar 2000) |
| hairy root culture | A relatively new type of plant culture, which consists of highly branched roots of a plant, covered with a mass of tiny root hairs. These cultures do not require hormones or vitamins to grow, so they can grow on simple media of salts and sugars. Just as importantly, they produce secondary metabolites at levels similar to those made in the original plant, so they can be used as replacement plants for making such compounds as food flavours and fragrances. (14 Nov 1997) |
| hairy shaker disease | Congenital disorder of lambs caused by a virus closely related to or identical with certain strains of bovine viral diarrhoea virus. (12 Dec 1998) |
| hairy tongue | A tongue with abnormal elongation of the filiform papillae, resulting in a thickened furry appearance. Synonym: glossotrichia, trichoglossia. (05 Mar 2000) |
| oral hairy leukoplakia | A whitish lesion that appears on the side of the tongue and inside cheeks. The lesion appears raised, with a ribbed or hairy surface. Oral hairy leukoplakia occurs mainly in people with declining immunity and may be caused by Epstein-Barr virus infection. (11 Jan 1998) |
| tongue, hairy | A benign condition of the tongue characterised by hypertrophy of the filiform papillae that give the dorsum of the tongue a furry appearance. The colour of the elongated papillae varies from yellowish white to brown or black, depending upon staining by substances such as tobacco, food, or drugs. (12 Dec 1998) |
| leukaemia, hairy cell | A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukaemia; it is characterised by an insidious onset, splenomegaly, anaemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of "hairy" or "flagellated" cells in the blood and bone marrow. (12 Dec 1998) |
| leukoplakia, hairy | Epithelial hyperplasia of the oral mucosa associated with epstein-barr virus and found almost exclusively in persons with HIV infection. The lesion consists of a white patch that is often corrugated or hairy. (12 Dec 1998) |
| acetylcholine receptor antibodies | <neurology, investigation> A test used to measure the amount of antibodies to acetylcholine receptors on nerve endings. This is a diagnostic test for myasthenia gravis. A normal value is no antibodies in the bloodstream. Acetylcholine receptor (AChR) binding autoantibodies (i.e. Antibodies reactive with several epitopes other than the binding site for acetylcholine or alpha-bungarotoxin) are present in approximately 88% of patients with generalised myasthenia gravis, 70% of ocular myasthenia and in approximately 80% of myasthenia gravis in remission. Although serum concentrations of AChR binding autoantibodies do not in general correlate well with severity of weakness, there is typical decrease in concentration as weakness improves with immunosuppressive therapy. AChR blocking autoantibodies (i.e., antibodies reactive with the AChR binding site) are present in about 50% of patients with myasthenia gravis, 30% with ocular myasthenia gravis and 20% of myasthenia gravis in remission, AChR blocking autoantibodies are the only AChR autoantibodies present in about 1% of myasthenia gravis. AChR modulating autoantibodies (i.e., autoantibodies which cross-link AChRs and cause their removal from muscle membrane surfaces) are present in more than 90% of myasthenia gravis and occasionally are the only AchR autoantibodies detectable in mild, recent onset or ocular-restricted myasthenia gravis. Results for AChR modulating autoantibodies can be transiently false-positive due to curare-like drugs used during general anesthesia. AChR autoantibodies of one or more types are found in at least 80% of ocular myasthenia gravis. Although generally absent in neurological conditions other than myasthenia gravis(and consequently unlikely to cause confusion in neurodiagnosis), false-positive results for AChR autoantibodies occasionally occur in primary biliary cirrhosis, tardive dyskinesia, autoimmune thyroiditis, the elderly, amyotrophic lateral sclerosis patients treated with cobra venom and patients with thymoma in the absence of myasthenia gravis. Approximately 1% of patients with rheumatoid arthritis treated with D-penicillamine develop AChR autoantibodies and myasthenia gravis, both of which disappear when the drug is discontinued. Babies born to ~10% of myasthenia gravis mothers have a transient neonatal form of myasthenia gravis that responds well to anticholinesterase therapy and usually remits within 1 month as maternal IgG disappears. (29 Dec 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|